DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Rogers ES, MacLeod RD, Stewart J, Bird SP, Keogh JW.
A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients--ACCeRT study.
BMC Cancer 2011;
11: 493
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.